Loredana Puca at Cornell University

University	Cornell University
Position	Postdoctoral fellow Weill Cornell Medicine
Citations(all)	4331
Citations(since 2020)	3596
Cited By	2095
hIndex(all)	19
hIndex(since 2020)	18
i10Index(all)	21
i10Index(since 2020)	19
Email	Access Email
University Profile Page	Cornell University
Google Scholar	View Google Scholar Profile

Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes

2024/2/8

Richa Singh

H-Index: 1

Loredana Puca

H-Index: 14

Sheng-Yu Ku

H-Index: 14

Myles Brown

H-Index: 74

Himisha Beltran

H-Index: 53

Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of disease

2023/9/14

The identification of CELSR3 and other potential cell surface targets in neuroendocrine prostate cancer

Cancer research communications

2023/8/3

Sheng-Yu Ku

H-Index: 14

Subhasree Basu

H-Index: 3

Etienne Dardenne

H-Index: 11

Loredana Puca

H-Index: 14

Olivier Elemento

H-Index: 70

Mark A Rubin

H-Index: 115

Himisha Beltran

H-Index: 53

Abstract NG10: Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets

Cancer Research

2023/4/4

Fanying Tang

H-Index: 2

Duo Xu

H-Index: 2

Shangqian Wang

H-Index: 15

Chen Khuan Wong

H-Index: 8

Sandra Cohen

H-Index: 22

Rohan Bareja

H-Index: 15

Loredana Puca

H-Index: 14

Himisha Beltran

H-Index: 53

Yu Chen

H-Index: 3

Ekta Khurana

H-Index: 30

Abstract P4-08-02: LOXO-783: A potent, highly mutant selective and brain-penetrant allosteric PI3Kα H1047R inhibitor in combination with standard of care (SOC) treatments in …

Cancer Research

2023/3/1

Loredana Puca

H-Index: 14

Rui Wang

H-Index: 3

Shuang Chen

H-Index: 5

LOXO-783: a potent, highly mutant selective and brain-penetrant allosteric PI3Kα H1047R inhibitor in combination with standard of care (SOC) treatments in preclinical PI3Kα …

CAL

2022/12/6

Loredana Puca

H-Index: 14

Carmen Perez

H-Index: 3

Rui Wang

H-Index: 3

Shuang Chen

H-Index: 5

Abstract B026: Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets

Cancer Research

2022/12/1

Fanying Tang

H-Index: 2

Duo Xu

H-Index: 2

Shangqian Wang

H-Index: 15

Chen Khuan Wong

H-Index: 8

Cindy Lee

H-Index: 32

Sandra Cohen

H-Index: 22

Rohan Bareja

H-Index: 15

Loredana Puca

H-Index: 14

Michael Berger

H-Index: 18

Lukas Dow

H-Index: 29

Himisha Beltran

H-Index: 53

Yu Chen

H-Index: 3

Ekta Khurana

H-Index: 30

Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets

Science

2022/5/27

Fanying Tang

H-Index: 2

Duo Xu

H-Index: 2

Shangqian Wang

H-Index: 15

Chen Khuan Wong

H-Index: 8

Sandra Cohen

H-Index: 22

Rohan Bareja

H-Index: 15

Loredana Puca

H-Index: 14

Himisha Beltran

H-Index: 53

Yu Chen

H-Index: 3

Ekta Khurana

H-Index: 30

Extracellular Matrix in Synthetic Hydrogel‐Based Prostate Cancer Organoids Regulate Therapeutic Response to EZH2 and DRD2 Inhibitors (Adv. Mater. 2/2022)

Advanced Materials

2022/1

Sungwoong Kim

H-Index: 6

Rohan Bareja

H-Index: 15

Zhou Fang

H-Index: 6

Heng Pan

H-Index: 6

Muhammad Asad

H-Index: 1

Ashley Doane

H-Index: 8

Richa Singh

H-Index: 1

Loredana Puca

H-Index: 14

Mark A Rubin

H-Index: 115

Himisha Beltran

H-Index: 53

Olivier Elemento

H-Index: 70

Ankur Singh

H-Index: 13

Abstract P142: Preclinical characterization of LOX-22783, a highly potent, mutant-selective and brain-penetrant allosteric PI3Kα H1047R inhibitor

Molecular Cancer Therapeutics

2021/12/1

Rui Wang

H-Index: 3

Loredana Puca

H-Index: 14

Carmen Perez

H-Index: 3

Yi Zheng

H-Index: 24

James Thomas

H-Index: 10

Erin Anderson

H-Index: 8

Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancer

Nature communications

2021/11/4

Weijie Zhang

H-Index: 9

Sheng-Yu Ku

H-Index: 14

Loredana Puca

H-Index: 14

Yuzhen Liu

H-Index: 1

Ting-You Wang

H-Index: 7

Rohan Bareja

H-Index: 15

Rendong Yang

H-Index: 17

Paari Murugan

H-Index: 14

Himisha Beltran

H-Index: 53

Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity

Nature communications

2020/11/3

Rohan Bareja

H-Index: 15

Paola Cavaliere

H-Index: 3

Noah Dephoure

H-Index: 29

Anne-Christine Uldry

H-Index: 10

Sandra Cohen

H-Index: 22

Loredana Puca

H-Index: 14

Felix Feng

H-Index: 71

Shangqian Wang

H-Index: 15

Himisha Beltran

H-Index: 53

Tamara Lotan

H-Index: 36

Marianna Kruithof-De Julio

H-Index: 18

Yu Chen

H-Index: 3

Francesca Demichelis

H-Index: 55

Salvatore Piscuoglio

H-Index: 36

Mark A Rubin

H-Index: 115

Chromatin accessibility profiles of castration-resistant prostate cancers reveal novel subtypes and therapeutic vulnerabilities

bioRxiv

2020/1/1

Fanying Tang

H-Index: 2

Shangqian Wang

H-Index: 15

Chen Khuan Wong

H-Index: 8

Sandra Cohen

H-Index: 22

Rohan Bareja

H-Index: 15

Loredana Puca

H-Index: 14

Himisha Beltran

H-Index: 53

Yu Chen

H-Index: 3

Ekta Khurana

H-Index: 30

Chromatin accessibility landscape and transcriptome of castration resistant prostate cancers reveals novel subtypes and diverse master regulators

2020/8/15

Fanying Tang

H-Index: 2

Chen Khuan Wong

H-Index: 8

Sandra Cohen

H-Index: 22

Cindy Lee

H-Index: 32

Rohan Bareja

H-Index: 15

Loredana Puca

H-Index: 14

Himisha Beltran

H-Index: 53

Yu Chen

H-Index: 3

Ekta Khurana

H-Index: 30

Extracellular microenvironment in patient-derived hydrogel organoids of prostate cancer regulates therapeutic response

medRxiv

2020/1/1

Rohan Bareja

H-Index: 15

Muhammad Asad

H-Index: 1

Loredana Puca

H-Index: 14

Himisha Beltran

H-Index: 53

Olivier Elemento

H-Index: 70

Ankur Singh

H-Index: 13

SLFN11 expression in advanced prostate cancer and response to platinum-based chemotherapy

Molecular cancer therapeutics

2020/5/1

Sheng-Yu Ku

H-Index: 14

Loredana Puca

H-Index: 14

Rohan Bareja

H-Index: 15

Olivier Elemento

H-Index: 70

Himisha Beltran

H-Index: 53

Loredana Puca

Cornell University

About Loredana Puca

Loredana Puca Information

Loredana Puca Skills & Research Interests

Top articles of Loredana Puca

Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes

Richa Singh

Loredana Puca

Sheng-Yu Ku

Myles Brown

Himisha Beltran

Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of disease

The identification of CELSR3 and other potential cell surface targets in neuroendocrine prostate cancer

Sheng-Yu Ku

Subhasree Basu

Etienne Dardenne

Loredana Puca

Olivier Elemento

Mark A Rubin

Himisha Beltran

Abstract NG10: Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets

Fanying Tang

Duo Xu

Shangqian Wang

Chen Khuan Wong

Sandra Cohen

Rohan Bareja

Loredana Puca

Himisha Beltran

Yu Chen

Ekta Khurana

Abstract P4-08-02: LOXO-783: A potent, highly mutant selective and brain-penetrant allosteric PI3Kα H1047R inhibitor in combination with standard of care (SOC) treatments in …

Loredana Puca

Rui Wang

Shuang Chen

LOXO-783: a potent, highly mutant selective and brain-penetrant allosteric PI3Kα H1047R inhibitor in combination with standard of care (SOC) treatments in preclinical PI3Kα …

Loredana Puca

Carmen Perez

Rui Wang

Shuang Chen

Abstract B026: Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets

Fanying Tang

Duo Xu

Shangqian Wang

Chen Khuan Wong

Cindy Lee

Sandra Cohen

Rohan Bareja

Loredana Puca

Michael Berger

Lukas Dow

Himisha Beltran

Yu Chen

Ekta Khurana

Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets

Fanying Tang

Duo Xu

Shangqian Wang

Chen Khuan Wong

Sandra Cohen

Rohan Bareja

Loredana Puca

Himisha Beltran

Yu Chen

Ekta Khurana

Extracellular Matrix in Synthetic Hydrogel‐Based Prostate Cancer Organoids Regulate Therapeutic Response to EZH2 and DRD2 Inhibitors (Adv. Mater. 2/2022)

Sungwoong Kim

Rohan Bareja

Zhou Fang

Heng Pan

Muhammad Asad

Ashley Doane

Richa Singh

Loredana Puca

Mark A Rubin

Himisha Beltran

Olivier Elemento

Ankur Singh

Abstract P142: Preclinical characterization of LOX-22783, a highly potent, mutant-selective and brain-penetrant allosteric PI3Kα H1047R inhibitor